Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MORENew Funding & Partnership Bolsters Support for First Global Adaptive Clinical Trial Platform for Brain Cancer Patients With new partnership agreement and philanthropic support, National Brain Tumor Society and StacheStrong make an additional investment into innovative GBM AGILE clinical trial National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced a second round of funding for the GBM AGILE clinical trial. Together with […] May 1, 2019
National Brain Tumor Society Issues Calls to Action During Brain Tumor Awareness Month 2019 Patient advocacy leader again declaring its community’s national recognition month as Brain Tumor Awareness ACTION Month National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that it’s recognizing Brain Tumor Awareness Month (BTAM) in 2019 with multiple calls to action as it renews the […] April 30, 2019
National Brain Tumor Society Welcomes Three New Members to its Board of Directors National Brain Tumor Society (NBTS), a leading nonprofit dedicated to the brain tumor community in the United States, recently expanded the expertise and leadership of its Board of Directors with the addition of three new members with diverse backgrounds spanning corporate strategy, marketing and consumer insights, and research and medical treatment of brain tumors. Joining […] March 19, 2019
National Brain Tumor Society and the Brain Science Foundation Partner to Fund Research for Most Common Brain Tumor Type Brain tumor nonprofits establish the Meningioma Research Fund to seek a cure and help thousands across the country National Brain Tumor Society (NBTS), a leading nonprofit dedicated to the brain tumor community in the United States, today announced a new partnership with the Brain Science Foundation (BSF). Under terms of the partnership, the organizations have […] February 19, 2019
National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma Brain Cancer NBTS provides $750,000 award to the Global Coalition for Adaptive Research to help launch innovative clinical trial for glioblastoma patients National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced a partnership with the Global Coalition for Adaptive Research (GCAR), a nonprofit organization comprised of some […] January 16, 2019